CellBion Co., Ltd. (KOSDAQ:308430)
South Korea
· Delayed Price · Currency is KRW 37,700
-250 (-0.66%)
At close: Apr 28, 2026
CellBion Market Cap
CellBion has a market cap or net worth of 483.75 billion as of April 28, 2026. Its market cap has increased by 118.06% in one year.
Market Cap
483.75B
Enterprise Value
469.46B
Revenue
1.95B
Ranking
n/a
PE Ratio
n/a
Stock Price
37,700.00
Market Cap Chart
Since October 16, 2024, CellBion's market cap has increased from 263.06B to 483.75B, an increase of 83.89%. That is a compound annual growth rate of 48.85%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 28, 2026 | 483.75B | 59.75% |
| Dec 30, 2025 | 302.82B | 100.48% |
| Dec 30, 2024 | 151.05B | -42.58% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| ImmuneOncia Therapeutics | 539.14B |
| HEM Pharma | 437.75B |
| Samyang Biopharm | 598.59B |
| Myung In Pharmaceutical LTD. | 827.82B |
| DAE HWA Pharmaceutical | 263.10B |
| NOVAREX | 262.17B |
| GREEN CROSS WellBeing | 251.98B |
| High Tech Pharm | 209.69B |